Skip navigation

no spam, unsubscribe anytime.
Skip navigation
Goal: 30,000 Progress: 5,713
Sponsored by: The Breast Cancer Site

Today, the vast majority of medical research is done on men, with women compromising only one-third of test subjects.

The cause and rationale behind this is a long and complex one. In 1977, the FDA recommended that women of childbearing age essentially be excluded from clinical trials after medical disasters like the Thalidomide tragedy and synthetic estrogen known as DES, which led to malignancies in reproductive organs. Women's bodies also go through considerably more change then men's in the forms of menstruation, pregnancy, and menopause which can complicate research data sets.

But for those women who are willing to participate in medical research studies, all of the above facts are reasons why men and women must be separated when it comes to medical research.

Symptoms of medical complications, such as heart attacks, are experienced differently in men and women. A general unfamiliarity of women's symptoms when they don't match men's has cost countless lives in the form of misdiagnosis. Women also absorb and react to medicine differently than men which can lead to complications and side-effects unanticipated by male-dominated drug trials.

Clearly, something needs to be done. Women's health needs cannot be ignored any longer. While there is wisdom in the decision to limit women's participation in studies to protect the unborn, those women who do choose to participate in studies should not have their results scrutinized under the same standards as men. Quite simply, male and female bodies are different, and medical data should treat them as such.

Ask the FDA Center for Drug Evaluation and Research to require studies to separate their results by male and female for the entire research process rather than lumping them together and to draw separate recommendations for the safe use of medicine for men and women.

Sign Here






To the Director of the FDA Center for Drug Evaluation and Research,

I am writing to you today to express my concern after discovering that the FDA does not require medical research and drug trials to separate their findings by the sex of their participants. To get better data on the way women respond to specific drugs and treatment, this must change.

As you are no doubt aware, women and men do not always display the same signs, symptoms, or reactions to treatment. Symptoms of medical complications, such as heart attacks, are experienced differently in men and women. A general unfamiliarity of women's symptoms when they don't match men's has cost countless lives in the form of misdiagnosis. Women also absorb and react to medicine differently than men which can lead to complications and side-effects unanticipated by male-dominated drug trials.

I understand that in 1977, the FDA recommended that women of childbearing age essentially be excluded from clinical trials after medical disasters like the Thalidomide tragedy and synthetic estrogen known as DES, which led to malignancies in reproductive organs. I also realize that women's bodies also go through considerably more change then men's in the forms of menstruation, pregnancy, and menopause which can complicate research data sets.

While there is wisdom in the decision to limit women's participation in studies to protect the unborn, those women who do choose to participate in studies should not have their results scrutinized under the same standards as men. Quite simply, male and female bodies are different, and medical data should treat them as such.

Women need to benefit from medical trials by having researchers separate their data by sex. Please, change your policies to require studies to separate their results by male and female for the entire research process rather than lumping them together and to draw separate recommendations for the safe use of medicine for men and women.

Thank you,

Petition Signatures


Jan 21, 2018 (Name not displayed)
Jan 21, 2018 Zack Stills
Jan 21, 2018 Linda Gutke
Jan 12, 2018 Debbie Drong
Jan 11, 2018 Tanja Stanfield
Jan 7, 2018 Rosemary Rannes
Jan 7, 2018 Thomas Friednan
Jan 4, 2018 Chelsea Rivera
Jan 3, 2018 sara Elkins
Jan 2, 2018 s w
Dec 27, 2017 Veronica Rehné
Dec 20, 2017 Sari Toivoniemi
Dec 20, 2017 Kristin Dito
Dec 20, 2017 (Name not displayed)
Dec 20, 2017 Karen Leifker
Dec 20, 2017 Linda Hanchett
Dec 20, 2017 Mary Jo Hajicek please look for our data!
Dec 20, 2017 Gail Lefèvre Another reason why I avoid pharmaceutical drugs like the plague.
Dec 20, 2017 Janet Liss
Dec 20, 2017 Mark Lungo
Dec 20, 2017 donna selquist
Dec 20, 2017 (Name not displayed)
Dec 20, 2017 Judi Merrow Women should be allowed to participate in studies so we know what is right for us.
Dec 20, 2017 Leslye Schoenhuth This is Unconscionable, especially when those drug are Aimed at Young Women..
Dec 20, 2017 Paul Schumann
Dec 20, 2017 (Name not displayed)
Dec 18, 2017 Robert Cooke, Jr.
Dec 15, 2017 Robert Ortiz
Dec 14, 2017 Heather Osborne
Dec 13, 2017 Donna Brock
Dec 6, 2017 Fredrik Pettersson
Dec 5, 2017 DayLynn McDonald
Dec 5, 2017 Melissa Miller
Dec 1, 2017 Rebecca Lambert
Dec 1, 2017 Joan Autry I thought this was settled long ago, but it looks like the chauvinistic medical establishment has done it again! Women are not 2nd -place citizens!
Dec 1, 2017 christine etapa
Dec 1, 2017 KAREN NILES
Nov 27, 2017 Rachel Brennan
Nov 27, 2017 Carol Maindonald
Nov 27, 2017 Misti Lee
Nov 25, 2017 Cindy Ray
Nov 25, 2017 Ashley Rozanski
Nov 24, 2017 (Name not displayed)
Nov 18, 2017 Jim Sheridan
Nov 17, 2017 Paul Statman
Nov 13, 2017 susan munro
Nov 7, 2017 Jodi Abel
Nov 7, 2017 Signe Dayhoff
Nov 7, 2017 Terri Lynch
Nov 7, 2017 Kimberly Boden

back to top

Elephant Parade Socks
Share this page and help fund mammograms: